Stewart Heather G, Andersen Peter M, Eisen Andrew, Weber Markus
Institute of Clinical Neurosciences, Umeå University Hospital, Umeå, Sweden.
Clin Neurophysiol. 2006 Aug;117(8):1850-61. doi: 10.1016/j.clinph.2006.04.004. Epub 2006 Jun 21.
To examine corticomotoneuronal function in amyotrophic lateral sclerosis (ALS) patients carrying superoxide dismutase 1 (SOD1) mutations using peristimulus time histograms (PSTH).
Six I113T, 3 A4V, one G41D and one G114A patient were studied along with 21 healthy control subjects. Analyses included comparison with previously reported data from 8 D90A homozygous and 12 sporadic ALS (SALS) patients examined by the authors using identical methodology.
Cortical threshold was significantly reduced in A4V patients (41.3%) compared to I113T (58%), SALS (57%) and D90A (71%) patients, as well as healthy controls (49.7%). Estimated excitatory postsynaptic potentials (EPSPs) were significantly larger in A4V patients (4.39 mV) compared to healthy controls (2.95 mV), I113T (2.71 mV) and SALS (2.39 mV) patients. Clinical features and PSTH parameters in I113T were similar to SALS, however, PSTH primary peaks (PP) were significantly more dispersed, 9.5 ms compared to 4ms in SALS. PSTHs from single G41D and G114A patients were unremarkable, apart from large EPSP amplitudes in the G114A patient.
ALS patients with A4V and I113T SOD1 mutations have distinctive corticomotoneuronal changes that are different from those in D90A homozygous and SALS patients.
PSTH studies should be considered for future in vivo studies of SOD1 pathophysiology in ALS.
使用刺激后时间直方图(PSTH)检查携带超氧化物歧化酶1(SOD1)突变的肌萎缩侧索硬化症(ALS)患者的皮质运动神经元功能。
对6例I113T、3例A4V、1例G41D和1例G114A患者以及21名健康对照者进行了研究。分析包括与作者先前使用相同方法检查的8例D90A纯合子和12例散发性ALS(SALS)患者报告的数据进行比较。
与I113T患者(58%)、SALS患者(57%)、D90A患者(71%)以及健康对照者(49.7%)相比,A4V患者的皮质阈值显著降低(41.3%)。与健康对照者(2.95 mV)、I113T患者(2.71 mV)和SALS患者(2.39 mV)相比,A4V患者的估计兴奋性突触后电位(EPSP)显著更大(4.39 mV)。I113T患者的临床特征和PSTH参数与SALS相似,然而,PSTH主峰(PP)的离散度显著更高,SALS为4毫秒,I113T为9.5毫秒。除G114A患者的EPSP振幅较大外,单个G41D和G114A患者的PSTH无明显异常。
携带A4V和I113T SOD1突变的ALS患者具有独特的皮质运动神经元变化,不同于D90A纯合子和SALS患者。
PSTH研究应被考虑用于未来ALS中SOD1病理生理学的体内研究。